JCR Pharmaceuticals Co., Ltd.

TSE:4552 Stock Report

Market Cap: JP¥79.3b

JCR Pharmaceuticals Management

Management criteria checks 2/4

JCR Pharmaceuticals' CEO is Shin Ashida, appointed in Jun 2005, has a tenure of 19.08 years. directly owns 0.008% of the company’s shares, worth ¥6.60M. The average tenure of the management team and the board of directors is 6.1 years and 4.5 years respectively.

Key information

Shin Ashida

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure19.1yrs
CEO ownership0.008%
Management average tenure6.1yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

Jul 12
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

May 22
JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Mar 18
JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Feb 29
JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

CEO

Shin Ashida (81 yo)

19.1yrs

Tenure

Mr. Shin Ashida has been the Chairman of JCR Pharmaceuticals Co., Ltd. since July 1995 and its Chief Executive Officer since June 2005. Mr. Ashida has been the President of JCR Pharmaceuticals Co., Ltd., s...


Leadership Team

NamePositionTenureCompensationOwnership
Shin Ashida
Chairman19.1yrsno data0.0083%
¥ 6.6m
Yoshihiro Ota
Director of Accounting Department & Corporate Strategy Department (Finance)no datano datano data
Yutaka Honda
Senior Corporate Officer8.1yrsno datano data
Hiroyuki Fukuya
Director of Legal Affairs Department - Administration Divisionno datano datano data
Toru Ashida
Senior VP of Sales & Administration4.3yrsno data0.21%
¥ 166.2m
Ryutaro Makino
Director of Marketing Dept. & Group Manager of Product Planning - Marketing Dept. for Sales Div.3.8yrsno datano data
Katsuya Nishino
Executive Vice President14yrsno datano data
Hiroshi Yoshimoto
Senior Advisor13.2yrsno datano data
Takayo Egawa
Corporate Officer & Director of International Affairs Officeno datano datano data
Hiroyuki Sonoda
VP of Research & Corporate Strategy6.1yrsno data0.0015%
¥ 1.2m
Mathias Schmidt
VP of Patient Association Response4.1yrsno datano data
Junichi Ando
Senior Corporate Officer & Executive Director of Production Division3.1yrsno datano data

6.1yrs

Average Tenure

62yo

Average Age

Experienced Management: 4552's management team is seasoned and experienced (6.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Shin Ashida
Chairman19.1yrsno data0.0083%
¥ 6.6m
Toru Ashida
Senior VP of Sales & Administrationno datano data0.21%
¥ 166.2m
Hiroyuki Sonoda
VP of Research & Corporate Strategy4.5yrsno data0.0015%
¥ 1.2m
Mathias Schmidt
VP of Patient Association Response4.5yrsno datano data
Yoshio Hiyama
Sr. Exec. Dir. of Quality Ass3.1yrsno data0.0013%
¥ 1.0m
Marc Dunoyer
Independent Outside Director1.5yrsno datano data
Philippe Fauchet
Independent Outside Directorno datano datano data
Toshihide Yoda
Independent Outside Directorno datano datano data
Toshihiro Ishikiriyama
Independent Outside Director9.1yrsno data0.0064%
¥ 5.1m
Yutaka Atomi
Independent Outside Director2.1yrsno datano data
Takashi Suetsuna
Independent Outside Directorno datano datano data
Yuko Hayashi
Independent Outside Directorno datano datano data

4.5yrs

Average Tenure

65.5yo

Average Age

Experienced Board: 4552's board of directors are considered experienced (4.5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.